Bank Julius Baer & Co’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $517K | Sell |
4,083
-324
| -7% | -$41K | ﹤0.01% | 378 |
|
2025
Q1 | $637K | Sell |
4,407
-98,490
| -96% | -$14.2M | ﹤0.01% | 343 |
|
2024
Q4 | $15M | Sell |
102,897
-2,074
| -2% | -$303K | 0.05% | 177 |
|
2024
Q3 | $18.1M | Sell |
104,971
-6,747
| -6% | -$1.16M | 0.06% | 137 |
|
2024
Q2 | $17.1M | Sell |
111,718
-175,042
| -61% | -$26.7M | 0.07% | 129 |
|
2024
Q1 | $39.3M | Sell |
286,760
-2,937
| -1% | -$403K | 0.15% | 99 |
|
2023
Q4 | $39.4M | Sell |
289,697
-3,400
| -1% | -$462K | 0.17% | 103 |
|
2023
Q3 | $35.8M | Buy |
293,097
+10,542
| +4% | +$1.29M | 0.21% | 91 |
|
2023
Q2 | $35.9M | Sell |
282,555
-5,904
| -2% | -$750K | 0.21% | 92 |
|
2023
Q1 | $37.3M | Buy |
288,459
+6,081
| +2% | +$785K | 0.24% | 96 |
|
2022
Q4 | $37.1M | Buy |
282,378
+6,368
| +2% | +$836K | 0.25% | 87 |
|
2022
Q3 | $32.3M | Buy |
276,010
+85,145
| +45% | +$9.96M | 0.25% | 86 |
|
2022
Q2 | $22.5M | Buy |
190,865
+171,832
| +903% | +$20.2M | 0.16% | 99 |
|
2022
Q1 | $2.48M | Sell |
19,033
-168,723
| -90% | -$22M | 0.01% | 207 |
|
2021
Q4 | $28.7M | Sell |
187,756
-3,490
| -2% | -$533K | 0.15% | 102 |
|
2021
Q3 | $30.9M | Buy |
191,246
+16,153
| +9% | +$2.61M | 0.19% | 90 |
|
2021
Q2 | $28.7M | Buy |
175,093
+2,215
| +1% | +$362K | 0.18% | 101 |
|
2021
Q1 | $26M | Sell |
172,878
-302
| -0.2% | -$45.5K | 0.19% | 100 |
|
2020
Q4 | $26.2M | Buy |
173,180
+857
| +0.5% | +$130K | 0.22% | 86 |
|
2020
Q3 | $23.3M | Sell |
172,323
-1,939
| -1% | -$263K | 0.23% | 83 |
|
2020
Q2 | $24.3M | Sell |
174,262
-2,069
| -1% | -$289K | 0.28% | 77 |
|
2020
Q1 | $19M | Buy |
+176,331
| New | +$19M | 0.44% | 63 |
|